SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp ($LAES) is trending as community members discuss its potential due to a new partnership focused on 'Made in US' post-quantum cryptography for defense and government agencies. Bullish sentiment is fueled by high trading volume and speculation that institutional investors are increasing their positions. Some traders are eyeing technical breakouts and potential short squeezes, while others remain cautious due to past dilution concerns.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

$SLV is trending as silver prices surge, driven by a combination of industrial demand and safe-haven buying amid economic uncertainty. Community members are discussing the potential for a continued rally, a short squeeze, and the possibility of silver reaching new all-time highs, while also weighing the risks of a pullback. Some investors are advocating for purchasing physical silver as a hedge against dollar devaluation.

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

Turn Therapeutics Inc.

Turn Therapeutics Inc

Turn Therapeutics ($TTRX) is trending after experiencing significant volatility following its recent IPO, with discussions focusing on potential short squeezes and the stock's trading behavior. Community members are actively debating entry and exit points, with some expressing bullish sentiment and others warning of a potential bull trap. The stock's high volume and price swings have made it a popular target for scalping and day trading.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is trending as the community discusses recent price action and the potential impact of the scPharmaceuticals acquisition, with some expressing concerns about management's performance and others anticipating positive news related to FDA filings or a potential buyout. The conversation also includes speculation about upcoming catalysts and the company's long-term prospects. Some traders are also discussing and analyzing different scenarios and possible targets.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending amidst volatile price action and high trading volume, sparking intense debate between bulls and bears regarding its valuation. Community discussions revolve around the potential for a pump and dump, an upcoming offering, and comparisons to other quantum computing stocks. Some traders point to a Barron's article highlighting the quantum sector as a potential bubble, while others maintain a long-term bullish outlook.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as discussions swirl around potential M&A activity in the weight loss and MASH space, particularly after recent acquisitions of competitors. The community speculates on potential buyout offers and partnerships, with some emphasizing the company's strong pipeline and potential for a short squeeze. Community members are actively discussing the likelihood of a buyout and the potential impact on the stock's valuation.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending due to a multi-year partnership with DoorDash to expand autonomous robot deliveries, starting in Los Angeles. The community is discussing the potential impact of this partnership on Serve's growth, comparing it to other robotics companies, and speculating on future price targets. Bullish sentiment is fueled by the company's partnerships with major delivery platforms and the potential for significant revenue growth.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as community members rally around the tokenization of Satoshi Nakamoto, viewing it as a fundamental representation of the crypto movement. The 'We are all Satoshi' narrative resonates deeply, with many believing it has limitless potential and comparing it to being early on Bitcoin. Discussions highlight the token's significance and its potential to become a globally recognized asset within the crypto space.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending after releasing a Q2 earnings report that beat expectations and led to reinstating their 2025 profit outlook, boosting investor confidence and lifting the entire airline sector. Community members are actively discussing whether the stock's momentum will continue, citing factors like potential tariff implications and labor costs as key influences. Analyst upgrades and positive sentiment from the CEO are also driving increased interest and bullish sentiment in the stock.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USAR is trending as community members discuss its potential following China's tightening of rare earth export restrictions, anticipating benefits for American rare earth producers. Discussions revolve around potential government stakes in the company, similar to other rare earth and lithium plays, and the company's strategic positioning in the sector. Some traders are also closely monitoring technical indicators for potential entry points, while others assess the impact of recent acquisitions on its supply chain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. biotech stocks, particularly small and mid-cap companies, remained a focal point for retail investors in 2024 despite significant volatility.&nbsp;Collectively, biotech stocks on U.S. bourses have garnered over 3.3 million watchers on Stocktwits.&nbsp;Here are the top five biotech stocks that saw the most significant surge in new followers this year:CERo Therapeutics Holdings Inc. (CERO): +44544% WatchersThis immunotherapy company develops engineered T-cell therapeutics for cancer. <a href="https://stocktwits.com/symbol/CERO">CERO</a> saw major retail interest following the FDA’s clearance of its lead compound, CER-1236, for Phase 1 clinical trials after an earlier clinical hold. The company went public via a SPAC merger in February and has lost 99% of its value this year.Psyence Biomedical Ltd. (PBM): +6741% WatchersKnown for developing natural psilocybin products for treating psychological trauma, PBM gained attention for positive results from its Phase IIb trial in adjustment disorder treatment for terminal cancer patients.&nbsp;Its&nbsp;shares have also dropped 99% this year since the company’s March SPAC debut.Azitra Inc. (AZTR): +2365% WatchersSpecializing in dermatological therapies using engineered proteins and live biotherapeutic products, AZTR drew attention for securing&nbsp;a fast track designation for ATR-04 and other multiple&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-are-azitra-shares-trending-on-wednesday/c7r4UW0RbE">patents</a>. Its stock value has plunged more than 99% since its debut in June last year.Immuneering Corporation (IMRX): +2248% WatchersFocused on oncology, IMRX’s lead program, IMM-1-104, received FDA orphan drug designation for pancreatic cancer and fast-track status to treat certain melanoma patients, and is currently in a Phase 2a trial. <a href="https://stocktwits.com/symbol/IMRX">IMRX shares</a> have declined over 70% year-to-date.NKGen Biotech Inc. (NKGN): +1260% WatchersNKGN develops autologous and CAR-NK cell therapies. Its SNK01 natural killer cell therapy for Alzheimer’s disease showed promising results, with 90% of patients maintaining or improving cognitive function. The candidate was cleared to progress into phase 2 clinical development, which will involve a larger group of 30 patients with moderate Alzheimer's disease. Shares, however, have fallen more than 66% this year.Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments, positioning them as key biotech names to watch heading into 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

Equity

NKGen Biotech to Showcase at Global Investment Conference

NKGen Biotech ( ($NKGN) ) has shared an update. NKGen Biotech, Inc. is set to join the H.C. Wainwright 26th Annual Global Investment Conference on...

Why NKGen Biotech (NKGN) Stock Is Skyrocketing

NKGen Biotech shares are trading higher by 32.5% Thursday morning. The company announced it will present new SNK01 biomarker data at the Alzheimer's Association International Conference.
read more...

Why NKGen Biotech Stock Is Moving Higher Monday

NKGen Biotech shares are trading higher Monday after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease.
read more...

What's Going On With Nano-Cap NKGen Biotech Stock On Monday?

Latest on NKGen Biotech Inc (NASDAQ: NKGN) as shares surge 25.2% on high volume. Insights into NK cell therapy for neurodegenerative diseases. Developments in Parkinson's and Alzheimer's...

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference

SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid ( CSF ) and plasma Tau proteins in Alzheimer's patients. The additional Phase 1 SNK01 trial data suggest...

12 acciones de salud en movimiento en la sesi n intrad a del 06/03/2024

Acciones al alza
Aptorum Gr (NASDAQ:APM) experimentaron un repunte del 680,24% para establecerse en los 11,31 d lares durante la sesi n del regular del mi rcoles.
NKGen Biotech (NASDAQ:NKGN...

NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer's Disease at the Tau2024 Global Conference

SANTA ANA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) ( NKGen or the Company ), a clinical-stage biotechnology company focused on the development and...

NKGen Biotech Enhances Strategic Partnership with Meteora Capital

NKGen Biotech (NKGN) has released an update. NKGen Biotech, Inc., once known as Graf Acquisition Corp. IV, has revised its deal with Meteora Capita...

NKGen Biotech Amends Key Agreement, Increases Prepayment Shortfall

NKGen Biotech (NKGN) has released an update to notify the public and investors about an entry into a material definitive agreement. NKGen Biotech...

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.

NKGen Biotech Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

NKGN
NKGen Biotech Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest NKGN News

NKGN NKGen Biotech Inc